Literature DB >> 29782024

Investigation of RNA Synthesis Using 5-Bromouridine Labelling and Immunoprecipitation.

Rikke H Kofoed1, Cristine Betzer2, Søren Lykke-Andersen3, Ewa Molska3, Poul H Jensen4.   

Abstract

When steady state RNA levels are compared between two conditions, it is not possible to distinguish whether changes are caused by alterations in production or degradation of RNA. This protocol describes a method for measurement of RNA production, using 5-Bromouridine labelling of RNA followed by immunoprecipitation, which enables investigation of RNA synthesized within a short timeframe (e.g., 1 h). The advantage of 5-Bromouridine-labelling and immunoprecipitation over the use of toxic transcriptional inhibitors, such as α-amanitin and actinomycin D, is that there are no or very low effects on cell viability during short-term use. However, because 5-Bromouridine-immunoprecipitation only captures RNA produced within the short labelling time, slowly produced as well as rapidly degraded RNA can be difficult to measure by this method. The 5-Bromouridine-labelled RNA captured by 5-Bromouridine-immunoprecipitation can be analyzed by reverse transcription, quantitative polymerase chain reaction, and next generation sequencing. All types of RNA can be investigated, and the method is not limited to measuring mRNA as is presented in this example.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29782024      PMCID: PMC6101095          DOI: 10.3791/57056

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  20 in total

1.  Genome-wide analysis of mRNA decay in resting and activated primary human T lymphocytes.

Authors:  Arvind Raghavan; Rachel L Ogilvie; Cavan Reilly; Michelle L Abelson; Shalini Raghavan; Jayprakash Vasdewani; Mitchell Krathwohl; Paul R Bohjanen
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

2.  Genetic regulatory mechanisms in the synthesis of proteins.

Authors:  F JACOB; J MONOD
Journal:  J Mol Biol       Date:  1961-06       Impact factor: 5.469

Review 3.  PCR inhibitors - occurrence, properties and removal.

Authors:  C Schrader; A Schielke; L Ellerbroek; R Johne
Journal:  J Appl Microbiol       Date:  2012-07-24       Impact factor: 3.772

4.  Splicing kinetics and transcript release from the chromatin compartment limit the rate of Lipid A-induced gene expression.

Authors:  Amy Pandya-Jones; Dev M Bhatt; Chia-Ho Lin; Ann-Jay Tong; Stephen T Smale; Douglas L Black
Journal:  RNA       Date:  2013-04-24       Impact factor: 4.942

5.  5-Alkynyl-2'-deoxyuridines: chromatography-free synthesis and cytotoxicity evaluation against human breast cancer cells.

Authors:  Srinivasarao Meneni; Ingo Ott; Craig D Sergeant; Adam Sniady; Ronald Gust; Roman Dembinski
Journal:  Bioorg Med Chem       Date:  2007-02-01       Impact factor: 3.641

Review 6.  Post-transcriptional gene regulation by mRNA modifications.

Authors:  Boxuan Simen Zhao; Ian A Roundtree; Chuan He
Journal:  Nat Rev Mol Cell Biol       Date:  2016-11-03       Impact factor: 94.444

7.  Polo-like kinase 2 modulates α-synuclein protein levels by regulating its mRNA production.

Authors:  Rikke H Kofoed; Jin Zheng; Nelson Ferreira; Søren Lykke-Andersen; Mauro Salvi; Cristine Betzer; Lasse Reimer; Torben Heick Jensen; Karina Fog; Poul H Jensen
Journal:  Neurobiol Dis       Date:  2017-06-23       Impact factor: 5.996

Review 8.  Transcriptional regulation and its misregulation in disease.

Authors:  Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

9.  Targeting alpha-synuclein with a microRNA-embedded silencing vector in the rat substantia nigra: positive and negative effects.

Authors:  Christina E Khodr; Amanda Becerra; Ye Han; Martha C Bohn
Journal:  Brain Res       Date:  2014-01-21       Impact factor: 3.252

10.  Use of Bru-Seq and BruChase-Seq for genome-wide assessment of the synthesis and stability of RNA.

Authors:  Michelle T Paulsen; Artur Veloso; Jayendra Prasad; Karan Bedi; Emily A Ljungman; Brian Magnuson; Thomas E Wilson; Mats Ljungman
Journal:  Methods       Date:  2013-08-21       Impact factor: 3.608

View more
  1 in total

1.  Rta is the principal activator of Epstein-Barr virus epithelial lytic transcription.

Authors:  Ahmed Ali; Makoto Ohashi; Alejandro Casco; Reza Djavadian; Mark Eichelberg; Shannon C Kenney; Eric Johannsen
Journal:  PLoS Pathog       Date:  2022-09-29       Impact factor: 7.464

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.